LETTERMOVIR 240 MG TABLET

🧪 Composition

• Active Ingredient: Letermovir
• Dosage Form: Oral Tablet
• Strength: 240 mg

✅ Uses

• Used for the prevention of Cytomegalovirus (CMV) infection and disease in eligible transplant recipients.
• Commonly prescribed for patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) and are at risk of CMV reactivation.
• May also be recommended for selected kidney transplant recipients based on current clinical guidelines and physician assessment.
• Helps reduce the risk of CMV-related complications after transplantation.

💉 Dosage

Take Letermovir 240 mg exactly as prescribed by your healthcare provider. The dosage and duration of treatment depend on the patient’s transplant status, medical condition, and any concurrent medications. Swallow the tablet whole with water, with or without food, and follow your physician’s instructions carefully.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your doctor about all medications you are taking, as Letermovir may interact with certain drugs.
• Regular monitoring may be required during treatment to assess overall health and treatment response.
• Report any unusual symptoms or side effects to your healthcare provider promptly.

📦 Storage

Store the tablets at room temperature in a cool, dry place away from moisture, heat, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Letermovir 240 mg is an effective antiviral therapy for the prevention of CMV infection and disease in eligible transplant recipients. When used under specialist supervision, it helps reduce the risk of CMV-related complications and supports successful post-transplant recovery. Always use this medication exactly as prescribed by your healthcare provider.